Baird (investment bank) & Jefferies

Baird (investment bank): Baird (investment bank) is acting as a bookrunning manager for the offering, contributing to the syndicate of underwriters.

Jefferies: Jefferies is acting as a joint lead bookrunning manager for the offering, contributing to the successful placement of shares.

Baird (investment bank): Baird (investment bank) is acting as a lead manager for the public offering by Enliven Therapeutics.

Jefferies: Jefferies is acting as a joint book-running manager for the public offering by Enliven Therapeutics, facilitating the sale of securities.

Baird (investment bank): Baird (investment bank) is a financial services firm that slashed Immutep's price target and downgraded its stock to Neutral after the trial failure, indicating a loss of confidence in the company's future.

Jefferies: Jefferies is an investment bank that downgraded Immutep's stock to Hold following the TACTI-004 trial discontinuation, reflecting the market's negative reaction.

Baird (investment bank): Baird (investment bank)>>> acted as a financial advisor for Novanta>>> in this acquisition.

Jefferies: Jefferies>>> acted as the sole financial advisor for Riverpoint Medical>>> in this transaction.